<DOC>
	<DOCNO>NCT01940991</DOCNO>
	<brief_summary>This study confirm efficacy safety single topical administration botulinum toxin type A compare placebo control treatment moderate severe crow 's foot line</brief_summary>
	<brief_title>Efficacy Safety Botulinum Toxin Type A Moderate Severe Crow 's Feet Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe crow 's foot line Female male , 18 65 year age good general health Women childbearing potential ( WOCBP ) must agree use effective method birth control course study Any neurological condition may place subject increase risk exposure Botulinum Toxin Type A Muscle weakness paralysis , particularly area receive study treatment Active skin disease irritation treatment area Deep dermal scarring , inability smooth crow 's foot line treat manually spread skin apart Treatment Botulinum Toxin Type A crow 's foot line last 6 month 3 month anywhere body</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>